Cyndeo Wealth Partners »

Neuphoria Therapeutics shares owned by Cyndeo Wealth Partners

Quarter-by-quarter ownership of Neuphoria Therapeutics (NEUP) shares owned by Cyndeo Wealth Partners from 13F filings

Historical chart of Cyndeo Wealth Partners investment in Neuphoria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neuphoria Therapeutics held by Cyndeo Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuphoria Therapeutics by Cyndeo Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $71k 10k 7.10
2025-03-31 $58k 10k 5.76

More positions owned by Cyndeo Wealth Partners

Microsoft Corporation (MSFT)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Abbvie (ABBV)
JPMorgan Chase & Co. (JPM)
Oracle Corporation (ORCL)
Meta Platforms Cl A (META)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Alphabet Cap Stk Cl A (GOOGL)
Abbott Laboratories (ABT)
First Tr Exchange Trad Fd Vi FST TR GLB FD (FTGC)
Vanguard Index Fds Small Cp Etf (VB)
First Tr Exchange-traded Core Investment (FTCB)

View all positions for Cyndeo Wealth Partners

Top funds holding Neuphoria Therapeutics

AdvisorShares Investments
Prosperity Wealth Management
Diadema Partners
Vanguard Group
Millennium Management
Jane Street
Geode Capital Management
Merck & Co
UBS Group
Tower Research Capital
Rhumbline Advisers
Morgan Stanley
FMR

View all funds holding Neuphoria Therapeutics